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Abstract
Exencephaly/anencephaly is one of the leading causes of neonatal mortality and the most extreme open neural tube
defect with no current treatments and limited mechanistic understanding. We hypothesized that exencephaly leads to
a local neurodegenerative process in the brain exposed to the amniotic fluid as well as diffuse degeneration in other
encephalic areas and the spinal cord. To evaluate the consequences of in utero neural tissue exposure, brain and
spinal cord samples from E17 exencephalic murine fetuses (maternal intraperitoneal administration of valproic acid at
E8) were analyzed and compared to controls and saline-injected shams (n= 11/group). Expression of apoptosis and
senescence genes (p53, p21, p16, Rbl2, Casp3, Casp9) was determined by qRT-PCR and protein expression analyzed by
western blot. Apoptosis was measured by TUNEL assay and PI/AV flow cytometry. Valproic acid at E8 induced
exencephaly in 22% of fetuses. At E17 the fetuses exhibited the characteristic absence of cranial bones. The brain
structures from exencephalic fetuses demonstrated a loss of layers in cortical regions and a complete loss of structural
organization in the olfactory bulb, hippocampus, dental gyrus and septal cortex. E17 fetuses had reduced expression
of NeuN, GFAP and Oligodendrocytes in the brain with primed microglia. Intrinsic apoptotic activation (p53, Caspase9
and 3) was upregulated and active Caspase3 localized to the layer of brain exposed to the amniotic fluid. Senescence
via p21-Rbl2 was increased in the brain and in the spinal cord at the lamina I-II of the somatosensory dorsal horn. The
current study characterizes CNS alterations in murine exencephaly and demonstrates that degeneration due to
intrinsic apoptosis and senescence occurs in the directly exposed brain but also remotely in the spinal cord.
Introduction
Exencephaly is the most severe form of all neural tube
defects (NTD) with an incidence of 3 every 10,000 preg-
nancies1. The neurulation process occurs during the fourth
week of human gestation and disrupted closure and absence
of calvaria result in exencephaly. The unprotected fetal
brain tissue undergoes progressive damage with advancing
gestational age due to exposure to chemical and mechanical
factors in the intrauterine environment2,3. In this severe
form of neural tube defect the brain is totally disorganized
with few defined structures4 and some functions are always
present5,6. Exencephaly becomes anencephaly during
gestation due this aggressive environment and the brain
tissue can be destroyed by 8−10 weeks of gestation7.
Acrania-exencephaly-anencephaly sequence theory was
proposed by the observation of exencephalic fetuses during
pregnancy and the later delivered with anencephaly8; this
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theory suggests a “peeling off” of the neural tissue which has
been demonstrated in mice at E18.5 9.
This malformation, incompatible with extrauterine life
and currently untreatable, is poorly investigated and the
degenerative mechanisms in the brain and the spinal cord
are not clearly defined.
The use of an exencephaly mice model, induced fol-
lowing maternal administration of the antiepileptic drug
Valproic Acid (VPA)10,11, in the current study allows
characterization of the neural damage present in the brain
and distal spinal cord of exencephalic fetuses to elucidate
the degenerative mechanisms involved in the pathogen-
esis of exencephaly before anencephaly occurs.
Material and methods
All experimental protocols were approved by the
Institutional Animal Care and Use Committee at The
Children’s Hospital of Cincinnati and followed guidelines
set forth in the National Institutes of Health Guide for
Care and Use of Laboratory Animals (IACUC 2013-0293).
Animal preparation and valproic acid (VPA) exposure
Timed-pregnant CD1 mice weighing 30−35 g (Charles
River Laboratories, Inc, Wilmington, MA), were individually
housed with a standard dark:light schedule (10:14; 22 °C)
and access to water and standard chow ad libitum. Valproic
acid (VPA; Sigma- Aldrich Chemical, St. Louis, MO) was
dissolved at room temperature in sterile water and used
within 1 h of preparation. Pregnant mice were injected IP
with 600mg/kg VPA on E8 at 10:00 hours (n= 22), mating
date was defined as E-1. Control (Sham) animals were
injected with the same volume of sterile water (n= 11)12.
Tissue samples: brain, spinal cord
On embryonic day 17 fetuses were collected into three
groups; exencephalic, internal control (nonexencephalic
littermates from VPA-treated dams), and Sham
(untreated dams). Whole brain and spinal cord samples
dissected for RNA and protein expression analysis were
dissected, snap frozen and stored at −80 °C. For histology
and immunofluorescence, fetuses were fixed for 24 h in
4% paraformaldehyde, processed and embedded in par-
affin. Samples for flow cytometry were dissected and
processed following the standard protocol for the neural
tissue dissociation kit (Miltenyi Biotec, Auburn, CA,
USA); briefly, neural tissue was digested with papain at
37 °C with rotation using a gentle MACS Dissociator
(Miltenyi Biotec, Auburn, CA, USA). Cell suspension was
passed through 70 µm cell strainer (BD) and labeled for
flow cytometry as described below.
RNA extraction and RT-qPCR
Tissues were homogenized (IkaT10 basic Ultra-Turrax
homogenizer, USA) in RLT buffer and RNA extracted
using the RNeasy Plus Mini Kit (Qiagen Science, Hilden,
Germany) following the manufacturer’s protocol. One
microgram of RNA was reverse transcribed using RT2
First strand Kit (Qiagen Sciences, MD, USA) and then run
on specific TaqManR Gene Expression Assays for: TPR53,
CDKN2A, CDKN1A, RBL2, Caspase3 and Caspase9
(Applied Biosystems, Foster City, CA, USA) (Supple-
mentary Table 1) and the 7500 Fast Real-Time PCR
System. Samples were performed in triplicate. The relative
expression fold change of mRNAs was calculated by the
2−ΔΔCt method on eight fetuses per group (n= 8).
Protein extraction
Proteins were extracted from total fetal brain and spinal
cord samples at E17 by sonication (Fisher Scientific,
Pittsburgh, PA, USA) in N-PER buffer (Thermo Fisher
Scientific, Rockford, IL, USA)+ Proteinase K+ Phos-
phoSTOP (Roche Diagnostics GmbH, Mannheim, Ger-
many) and centrifuged at 10,000 rpm for 5 min. Protein
concentration was assessed using the BCA-mini kit
(Thermo Scientific, Rockford, IL, USA).
Western blot
Brain and spinal cord homogenates on six animals per
group (n= 6) were loaded onto 4−12% acrylamide gels
and transferred to PVDF membranes (Life Technologies,
CA, USA). After blocking with BSA (5%) for 1 h, mem-
branes were hybridized with primary antibody: anti-NeuN
(1:1000, Abcam, Cambridge, MA, USA), anti-GFAP
(1:1000, Dako, Carpinteria, CA, USA), anti-
oligodendrocyte (1:250, Abcam, Cambridge, MA, USA),
anti-Iba1 (1:1000, Wako, Richmond, VA, USA), anti-p21
(1:500, Abcam, Cambridge, MA, USA) and anti-ß-Actin
(1:10,000, Abcam, Cambridge, MA, USA) overnight at 4 °C.
Membranes were washed and hybridized with appropriate
secondary antibody (1:10,000, Abcam, Cambridge, MA,
USA) for 1 h at RT and visualized using SuperSignal
WestPico Chemiluminescent substrate (Thermo Scien-
tific, Rockford, USA). Protein expression was quantified
by densitometry using ImageJ (National Institutes of
Healt, Bethesda, MD) and normalized to ß-Actin.
Histological analysis
Sagittal sections of the brain and spinal cord cross
sections were fixed in formalin for 48 h and processed and
embedded in paraffin blocks. Histology was performed on
5 μm sections from sagittal brain and spinal cord cross
sections including the periventricular region, brain stem
and cerebellum. Hematoxylin and eosin (H&E) staining
was performed using a Varistain Gemini ES autostainer
(Thermo Scientific). A 1:4 mixture of Mayer’s Hematox-
ylin (Lillie’s Modification) histological Staining Reagent
(Dako Carpinteria, CA, USA) and Automation Hema-
toxylin Staining Reagent (Dako Carpinteria, CA, USA)
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was used with a 0.25% Eosin-Y (Richard Allen Scientific)
for contrast.
Immunofluorescence
Sections (5 µm) of fetal brain and spinal cord were
dried, permeabilized with 0.1% Triton X-100 (Sigma
Aldrich, St. Louis, MO, USA) in PBS and blocked for 1 h
in 5% BSA at RT. Sections were incubated with primary
antibody; anti-GFAP (1:1000, DAKO, Carpinteria, CA,
USA), anti-Iba1 (1:1000, Wako, Richmond, VA, USA),
anti-p21 (1:500, Abcam, Cambridge, MA, USA), anti-
Cleaved Caspase 3 (1:500, Cell Signalling, Danvers, MA,
USA), overnight at 4 °C in a humid chamber. Slides were
washed and incubated for 1 h with Alexa Fluor 488 or 568
labeled secondary antibodies (1:1000, Life Technologies,
Eugene, OR, USA) at RT in the dark. Slides were washed
and mounted in mounting media with DAPI (South-
ernBiotech, Birminghan, AL, USA).
Neurotracer assay
Neurotracer assay (Life Technologies, Eugene, OR,
USA) was performed on 5 µm sections of fetal brain and
spinal cord following the manufacturers’ instructions to
identify and visualize neurons.
TUNEL assay
TUNEL assay (Roche, Diagnostics GmbH, Mannheim,
Germany) was performed following the manufacturers’
instructions on brain and spinal cord at E17 to analyze
apoptosis/cell death13.
Flow cytometry with Annexin V (AV) and Propidium Iodide
(PI)
Phosphatidyl-serine is located on the inner part of the
plasma membrane facing the cytosol in normal, live cells,
but during apoptosis it is translocated to the cell surface
and can be labeled with Annexin V (AV). The vital dye
propidium iodide (PI) was used to determine cell mem-
brane injury in the single-cell suspension from neural
tissue. The percentage of cells labeled as PI+AV+ (late
apoptosis), PI+AV− (necrosis), PI−AV+ (early apop-
tosis) and PI−AV− (live cells) were quantified following
flow on an LSR III (BD Biosciences, San Jose, CA, USA)
and FlowJo (FlowJo LLC, Ashland OR, USA) analysis
software.
Statistical analysis
Results are expressed as means ± standard error (SE) for
relative gene expression (2-ΔΔCt) and means ± standard
deviation (SD) for protein expression. Inter-group com-
parisons were performed with the unpaired Student’s t
test considering a P value of <0.05 significant. GraphPad
Prism 7 (GraphPad Software Inc., La Jolla, CA, USA)
package was used for statistical calculations.
Results
Loss of layer organization in VPA-induced exencephalic
fetuses
Twenty-two percent of the fetuses developed exence-
phaly following maternal administration of VPA. We
observed typical alterations seen in exencephalic fetuses
with absent frontal, parietal and occipital bones (Fig. 1b).
At E17 exencephalic fetuses demonstrated a lack of
structural organization in areas such as the olfactory bulb,
hippocampus, dental gyrus, and septal complex, with
evidence of collapsed ventricles (Fig. 1b, f). The brain
stem was hypertrophic (Fig. 1b, f) and the cerebellum
atrophied with no circumvolutions nor cortical layer
organization (Fig. 1d, h). Control fetuses from nonaffected
littermates and those from sham mothers demonstrated
normal brain development and structural organization
(Fig. 1a–g).
The exencephalic brain cortex showed no layered cell
organization (marginal zone, cortical plate, sub plate and
intermediate zone) (Fig. 1l–n) compared to littermate
controls and sham (Fig. 2a–c)14. Derangement of neurons
was observed in the gray matter with neuronal cells ran-
domly arranged from the superficial molecular layer to
the deeper cortical layer, without laminar organization
(Fig. 1i, k).
Reduction of neuronal and glial protein expression in
exencephalic fetuses
The brains of the exencephalic fetuses showed lower
protein expression of NeuN, GFAP, Oligodendrocyte
compared to control and sham group (p < 0.005); in
contrast, exencephalic fetuses showed increased Iba1
protein expression in the brain compared to sham and
littermate controls (Fig. 2a). Immunofluorescence for
Neurotracer in the brain corroborates these results
(Fig. 2b–e). The exencephalic fetuses showed dispersed
neuronal distribution with no structural organization or
visible cortical distribution (Fig. 2d, e) compared with
control and sham fetuses at E17 in which the outline of
the dentate gyrus, including the hippocampal fissure, was
clearly identifiable (Fig. 2b) along with the cortical pro-
jections (Fig. 2c).
At embryonic day 17 in normal brain development,
GFAP expression is limited to cells in the ventricular
zone (VZ), suprafimbrial region, subpial region between
the fimbria and the dentate gyrus (Fig. 2f, g)15. These
astrocytes (GFAP positive cells) are the migrating cell
population that contribute to the formation of the
dentate granule cell layer, but not the pyramidal cell
layer as Seki et al. previously described16. In exence-
phalic fetuses at E17 the astrocytes (GPAP positive
cells) are expressed in the layers in contact with the
ventricles as a potential VZ but lack a well-defined
pattern (Fig. 2h, i).
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In control littermates and sham fetuses, microglial
expression of Iba1 is limited to the brain cortex at E17
(Fig. 2j) and Iba1-positive cells showed a resting pheno-
type, with extended projections (Fig. 2k). In contrast, in
the exencephalic fetuses there was an increase in numbers
of microglia demonstrating activated morphology (Fig. 2l, m)
and these were mainly expressed in the layers exposed to
amniotic fluid.
Fig. 1 Brain maldevelopment in VPA-induced exencephaly. Sagittal section of normal (a) and exencephalic (b) fetal head at E17 (4× H&E);
Cerebellum and brain stem in normal fetuses (c) and hypertrophic brain stem in exencephaly fetuses (d) (10×, H&E); normal structured cortex (e) and
brain cortex with no structures in exencephaly (f) (20×, HE) and cerebellum with cortical layers and circumbulutions in normal fetus (g) and
nonstructured mass in exencephalic fetuses at E17 (h) (20×, HE). C cortex, CB cerebellum, BS brain stem. Normal cortical layer organization in Sham
(i–k) and loss of any cellular layer organization in exencephaly (l–n) (10×, 20× and 40×, HE). MZ marginal zone, CP cortical plate, SP sub plate, IZ
intermediate zone
Oria et al. Cell Death and Disease          (2019) 10:721 Page 4 of 11
Official journal of the Cell Death Differentiation Association
Fig. 2 (See legend on next page.)
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Detection of necrosis, apoptosis and senescence in VPA-
induced exencephalic fetuses
Following VPA exposure and nonclosure of cranial
bones, neural tissue remains exposed to the amniotic
fluid. Exencephalic fetuses at E17 exhibited necrosis/cell
death in the cell layer exposed to amniotic fluid (Fig. 3c, d).
In controls, no cells in the inner brain and minimal
cells in the outer layers stained positive with TUNEL
(Fig. 3a, b)
The percentage of necrotic and late apoptotic cells,
(AV−/PI+ and AV+/PI+) were significantly increased in
exencephalic brains (Fig. 3f, j) compared to control and
sham fetuses (Fig. 3f, i) (*p < 0.05). No changes were seen
in the number of live, AV−PI−, and early apoptosis,
AV+/PI events (Fig. 3e). Furthermore, no differences were
seen in the cell populations of the spinal cord (Fig. 3g, h).
Overexpression of intrinsic apoptosis pathway in the brain
and spinal cord of VPA-induced exencephalic fetuses
Exencephalic fetuses had increased brain expression of
the intrinsic apoptosis genes p53, Caspase 9 and 3 but
only showed increased Caspase 3 expression in the
spinal cord (*p < 0.05, Fig. 4a). Activated Caspase 3 was
expressed in the layers of the neural tissue exposed to
amniotic fluid in exencephalic fetuses (Fig. 4d) and in
the nonexposed spinal cord (Fig. 4e) when compared
with normal and sham neural tissue (Fig. 4b, c).
Local and diffuse overexpression of cdkn1a (p21)-
Retinoblastoma (Rbl2) in the brain and spinal cord of VPA-
induced exencephalic fetuses
Exencephalic fetuses also exhibited increased gene
expression of senescence-related genes p21, p16 and Rbl2
in the brain and p21 and Rbl2 in the spinal cord compared
to the control and sham group (*p < 0.05, n= 6, Fig. 5a).
This increase was reflected at the protein level (Fig. 5h)
and localized by immunofluorescence to scattered neu-
rons in the brain (Fig. 5e). P21-positive neurons were also
identified in the lamina I and II in the posterior horn of
the spinal cord (Fig. 5f, g). No p21 expression was found
in the brain (Fig. 5b) nor the spinal cord of control and
sham fetuses (Fig. 5c, d).
Discussion
In this study, we described the activated mechanisms of
the central nervous system in the valproic acid-induced
murine model of exencephaly. We analyzed changes on
day 17 of gestation in the brain and the spinal cord to
characterize the effect of direct exposure and indirect
exposure to amniotic fluid. Focusing on day 17 we char-
acterized the alterations in the CNS prior to total
destruction of the brain tissue (anencephaly) to under-
stand the mechanisms involved in the pathophysiology of
this model9. This point in gestation is crucial to under-
stand the neurodegenerative and maldevelopment
mechanisms of the brain exposed to amniotic fluid as well
as the indirect effect on neurodegeneration in other fur-
ther areas of the CNS such as the spinal cord, which is not
exposed to the chemical and mechanical actions of the
amniotic fluid. Similar effects occur in other open neural
tube defects like open spina bifida in which the spinal
cord exposure to amniotic fluid induced progressive
neurodegeneration with neuroinflammatory response3.
VPA causes lack of skull protection to the developing
brain, which generates severe disruption to the laminar
architecture of the cerebral cortex17. We found no
structural tissue organization in exencephalic fetuses, and
the brain protrudes like a mass of tissue when exposed to
the aggressive AF environment. Neurons are not orga-
nized in the expected layers and axonal projections are
not identifiable. There is variability among fetuses in the
shape of the exposed brain and the degree of neural tissue
loss. Furthermore, architecture also is disrupted in regions
with reduced cellular density.
We found a reduction in the total protein expression of
neurons, oligodendrocytes and astrocytes that corrobo-
rate with previous studies using the same teratogen18. In
our model, GFAP expression in migrating astrocytes is
restricted to the area around the ventricles in the exen-
cephalic fetuses. GFAP expression in the developing
mouse brain follows the basic progression of developing
radial glia and astrocytes. GFAP expression can be
detected earlier in normal mice with the radial glia genesis
around the telencephalic VZ19 and then in the fim-
bria20,21. At E17 in normal mice we observed astrogenesis
(see figure on previous page)
Fig. 2 Downregulation of neurons, astrocytes, oligodendrocytes and upregulation of microglia in the exencephalic brains. Western blot
analysis showed a clear reduction in protein expression levels in the brain of a neurons (NeuN), astrocytes (GFAP) and oligodendrocytes. Also, an
increase of the protein expression of microglia (Iba1) in brain lysates from exencephaly vs. normal and vs. Sham group (*p < 0.05) (n= 6−8). Neuronal
marker staining (Neurotracer) showed normal structured brain (b) with normal layer organization in the cortex (c) at E17 in normal fetuses at E17
compared with no neuronal organization in exencephalic fetuses (d, e). GFAP+ cells expressed in the ventricular zone, dentate gyrus and fimbria in
normal brain at E17 (f, g). GFAP+ cells are restricted around the ventricle in exencephalic mice (h, i). Neurotracer (green), GFAP (red) and DAPI (blue)
(20× and 40×). Microgliosis at the external layers of the brain exposed to the amniotic fluid with activated morphology in exencephalic brain
with activated morphology (l,m) compared with less expression in normal fetuses with resting phenotype (j, k). Iba1 staining (green) (20× and 100×)
(n= 6–8)
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Fig. 3 Increased necrosis/apoptosis in exencephaly brains VPA-induced mice. Brain sections of control fetuses at E17 (a, b) with minimal
TUNEL-positive cells (green) and exencephalic brains (c, d) with TUNEL-positive cells in exposed brain to the amniotic fluid (a and c 40×) (b and d
40×). The apoptosis/necrosis analysis by flow cytometry with PI and Annexin V in the brain (e, f) and spinal spinal cord (g, h), % population mean
(±SD) (n= 6). Exencephalic brains show higher % of cells PI+ AV+ (necrosis) and PI− AV+ (late apoptosis) (f, j) (*p < 0.05, **p < 0.001) than control
and sham fetuses (f, i). No differences seen in the spinal cord (g, h) (n= 6–8)
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which was not seen in the exencephalic fetuses. Exence-
phalic mice at E17 resembled normal mice at E9.5−E11
with expression of only the first radial glia22.
Using flow cytometry, we evaluated necrosis and
apoptosis in the neural tissue of the brain directly exposed
to the amniotic fluid and indirectly in the spinal cord.
Fig. 4 Exencephaly activates apoptotic genes in the brain and spinal cord. Relative gene expression for intrinsic apoptotic genes (p53, Caspase3
and Caspase9) in brain and spinal cord (a). Exencephalic fetuses at E17 showed upregulation of p53, Caspase3 and Caspase9 in the brain for and
Caspase3 in the spinal cord vs. Sham and Control group (*p < 0.05, **p < 0.001). Caspase 3-positive cells (green) in the region exposed to the amniotic
fluid in exencephalic brains (d) and scattered staining of active Caspase 3 in the spinal cord (e). No Caspase3 is seen in the brains nor spinal cords
from normal fetuses at E17 (b, c) (n= 6–8)
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Fig. 5 Senescence via p21 in VPA-induced exencephalic fetuses at E17. The relative expression of senescence genes (p21, p16 and Rbl2) in brain
and spinal cord (a) of exencephalic fetuses at E17 showed upregulation of p21-p16-Rbl2 senescence pathway in the brain and p21-Rbl2 in the spinal
cord. Exencephaly vs. Sham and Control groups (*p < 0.05). p21-positive cells (green) in the brain are scattered in clustered cell groups in
exencephalic brains (e) and expressed in the lamina I and II of the spinal cord (f, g). No expression of p21 was seen in normal brains nor spinal cords
at E17 (b–d). Relative protein expression of p21 by western blot in brain and spinal cord tissue from normal and exencephalic fetuses at E17 of
gestation (h) (*p < 0.05) (n= 6–8)
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Analyzing the early, late apoptotic and necrotic cells from
the CNS tissue by flow cytometry and the histological
images demonstrate the effect of the in utero environment
to the exposed cell layers2,23. This exponential chemical
action due to enzymes present in the amniotic fluid
increases during late gestation24 and physical action by
friction with the amniotic membranes2 could be the
mechanism inducing apoptosis in the external layers of
the brain but not in the protected areas, such as the spinal
cord. In those areas directly exposed to the amniotic fluid,
we observed a neuroinflammatory response involving
microglia activation. While microglia are the resident
macrophage population of the CNS, their function is
more than being the first immune sentinel cell, they also
contribute to CNS homeostasis and cell proliferation.
However, over reactive microglia leads to neural degen-
eration in neural tube defect injured tissues3.
The continued cell death in the brain layers exposed to
amniotic fluid lead to an indirect disruption to the spinal
cord. These alterations were detected by upregulation of
the intrinsic apoptotic genes p53 and Caspase 9 and 3
genes in the exposed brain tissue but also in the spinal
cord of the fetuses with exencephaly. Apoptotic cells were
detected in the external layers of the brain exposed to the
amniotic fluid. This apoptosis could underlie the func-
tional locomotor alterations with abnormal motor beha-
vior that anencephalic fetuses show after birth25,26. Also,
the activation of these apoptotic markers in the spinal
cord could determine diffuse progression of the cortico-
motor deficits and the loss of reflex5.
Both growth arrest and apoptosis are associated with
the induction of p53, particularly in response to DNA
damage or other modes of cellular stress27. We observed
upregulation of CDKN1A (p21) and retinoblastomas
protein (Rbl2) in the exencephalic mice in the brain;
however, there was no specific pattern of cells expressing
p21 in the brain which may be due to the lack of
cytoarchitecture and structural organization. It is possible
these p21-positive neurons are from the hippocampus as
has previously been described28.
Interestingly, p21-positive cells were found in the
lamina I and II at the Subtantia Gelatinosa of the dorsal
horn in the absence of activation of apoptotic genes (p53,
Caspase 3 or Caspase 9) in that region. These results
suggest that the somatotopically areas are in a senescent
state probably due to the loss of the somatosensory cir-
cuits in the brain. The loss of the neurons in the brain,
including the somatosensory brain areas, and the altera-
tion of motor responses by the progressive and continued
abrasion of the brain layers by the amniotic fluid plus the
internal disruption affect the sensory neurons in the
dorsal horn29. Further experiments with neuronal tracers
are needed to reveal if the p21-positive cells in the brain
and the spinal cord are part of the same neuronal circuits.
Conclusion
Exencephaly is one of the leading causes of fetal and
neonatal mortality as the most extreme open neural tube
defect. There are currently no treatments, and the etiology
and progression of this lethal malformation are poorly
investigated. The current study analyzing CNS disrup-
tions in exencephalic fetal mice demonstrates neurode-
generation due to extrinsic local cell death, but also by
intrinsic apoptosis and senescence in both the brain and
spinal cord. This local and diffuse cell degeneration may
contribute to the devastating neurological alterations seen
at birth.
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